Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a commonly used class of antidiabetic medications in the treatment of type 2 diabetes mellitus and obesity management, and it is important to understand public awareness and attitudes toward GLP-1 RAs. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.